Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	287.2	5.75	-78.02	-108.18	-180.97
Depreciation & Amortization	19.45	19.45	11.65	2.71	2.76
Stock-Based Compensation	14.68	31.6	45.31	32.3	31.24
Other Adjustments	-176.89	-17.85	-6.79	0.46	10.9
Change in Receivables	-4.91	-12.46	-10.61	1.93	-15.42
Changes in Inventories	-6.46	0.48	-15.87	-9.07	-5.64
Changes in Accounts Payable	-1.87	0.86	1.24	-0.79	-
Changes in Accrued Expenses	-4.66	13.33	12.15	1.49	4.08
Changes in Unearned Revenue	3.67	5.79	3.76	3.05	-
Changes in Other Operating Activities	5.45	-2.55	3.71	-3.42	-4.65
Operating Cash Flow	135.66	44.39	-33.46	-79.53	-157.69
Operating Cash Flow Growth	205.62%	-	-	-	-
Capital Expenditures	-0.25	-0.28	-0.72	-0.29	-0.3
Purchases of Intangible Assets	-	-	-	-	-1.2
Purchases of Investments	-526.65	-545.83	-523.5	-523.99	-438.96
Proceeds from Sale of Investments	494.13	585.42	529.38	464.32	354.43
Other Investing Activities	-	-0.04	-11.86	-0.66	-17.84
Investing Cash Flow	-32.77	39.26	-6.71	-60.63	-103.87
Issuance of Common Stock	14.95	9.27	7.17	3.47	221.11
Repurchase of Common Stock	-107.92	-46.37	-2.28	-1.04	-
Net Common Stock Issued (Repurchased)	-92.97	-37.1	4.9	2.43	221.11
Other Financing Activities	-13.14	-11.99	-10.03	-	-
Financing Cash Flow	-106.11	-49.09	-5.13	2.43	221.11
Net Cash Flow	-3.22	34.56	-45.3	-137.73	-40.45
Free Cash Flow	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Growth	206.99%	-	-	-	-
FCF Margin	47.84%	18.76%	-19.47%	-59.55%	-346.44%
Free Cash Flow Per Share	0.98	0.30	-0.24	-0.56	-1.16
Levered Free Cash Flow	302.53	42.82	-62.09	-114.51	-184.73
Unlevered Free Cash Flow	279.27	33.45	-76.42	-119.72	-185.26

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q